STE STERIS plc

  1. Stocks
  2. Healthcare
  3. NYSE: STE

Price (delayed)

$200.44

Market cap

$19.77B

P/E Ratio

187.33

Dividend/share

$1.84

EPS

$1.07

Enterprise value

$22.84B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
The revenue has grown by 8% YoY and by 3.6% from the previous quarter
STE's gross profit is up by 7% year-on-year
STERIS's quick ratio has increased by 6% YoY but it has decreased by 2.9% from the previous quarter
The company's EPS has shrunk by 57% YoY
The company's net income has shrunk by 56% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.steris.com/
Peers: SYK TMO OMI ECL

Key stats

What are the main financial stats of STE
Market
Shares outstanding
98.65M
Market cap
$19.77B
Enterprise value
$22.84B
Valuations
Price to earnings (P/E)
187.33
Price to book (P/B)
3.27
Price to sales (P/S)
4.01
EV/EBIT
85.68
EV/EBITDA
27.87
EV/Sales
4.61
Earnings
Revenue
$4.96B
EBIT
$266.55M
EBITDA
$819.45M
Free cash flow
$409.57M
Per share
EPS
$1.07
Free cash flow per share
$4.13
Book value per share
$61.21
Revenue per share
$49.94
TBVPS
$40.16
Balance sheet
Total assets
$10.82B
Total liabilities
$4.73B
Debt
$3.27B
Equity
$6.08B
Working capital
$1.15B
Liquidity
Debt to equity
0.54
Current ratio
2.33
Quick ratio
1.32
Net debt/EBITDA
3.74
Margins
EBITDA margin
16.5%
Gross margin
43.6%
Net margin
2.2%
Operating margin
5.4%
Efficiency
Return on assets
1%
Return on equity
1.8%
Return on invested capital
4.5%
Return on capital employed
2.7%
Return on sales
5.4%
Dividend
Dividend yield
0.92%
DPS
$1.84
Payout ratio
172%

STE stock price

How has the STERIS stock price performed over time
Intraday
-0.38%
1 week
-2.56%
1 month
9.62%
1 year
-13.12%
YTD
8.53%
QTD
4.79%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$4.96B
Gross profit
$2.16B
Operating income
$268.19M
Net income
$107.03M
Gross margin
43.6%
Net margin
2.2%
STE's operating income has soared by 99% from the previous quarter but it is down by 37% YoY
STE's operating margin has surged by 93% since the previous quarter but it is down by 42% year-on-year
STERIS's net margin has plunged by 58% YoY
The company's net income has shrunk by 56% YoY

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
STE P/E details
P/E
187.33
P/B
3.27
P/S
4.01
EV/EBIT
85.68
EV/EBITDA
27.87
EV/Sales
4.61
The company's EPS has shrunk by 57% YoY
The company's equity fell by 7% YoY
STE's P/B is 5% above its last 4 quarters average of 3.1 but 3.8% below its 5-year quarterly average of 3.4
The P/S is 9% below the 5-year quarterly average of 4.4 but 2.8% above the last 4 quarters average of 3.9
The revenue has grown by 8% YoY and by 3.6% from the previous quarter

Efficiency

How efficient is STERIS business performance
STERIS's ROIC has soared by 96% from the previous quarter but it has decreased by 34% YoY
The company's return on sales has surged by 93% QoQ but it fell by 39% YoY
STERIS's ROA has plunged by 52% YoY
The ROE has plunged by 51% YoY

Dividends

What is STE's dividend history
Dividend details
DPS
$1.84
Dividend yield
0.92%
Payout ratio
172%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 129% more than the total liabilities
STERIS's current ratio has increased by 14% YoY but it has decreased by 6% QoQ
STERIS's quick ratio has increased by 6% YoY but it has decreased by 2.9% from the previous quarter
STERIS's debt is 46% less than its equity
STE's debt to equity is up by 8% year-on-year
The company's equity fell by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.